English | Español
Ruth de Jauregui | Apr 2, 2017

FDA approves Dupixent for atopic dermatitis
Robert Hadley | Apr 2, 2017

FDA gives priority review to Eagle Pharmaceutical's heat stroke drug
Robert Hadley | Apr 2, 2017

Bristol-Myers Squibb's Opdivo cancer drug closer to approval in Europe
Kyle Perrotti | Apr 2, 2017

Keeping pets healthy vital for patients with weak immune systems

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’